MongoDB (MDB) faces mixed investor sentiment due to AI uncertainties, but modest upside is good enough to support the stock, considering rising enterprise adoption and the extended visibility offered by its recovery point objective coverage, Oppenheimer said Tuesday.
The brokerage said its checks suggest stable Atlas consumption, sales execution, and win rates, driving healthy net annual recurring revenue expansion and Atlas growth.
Oppenheimer sees potential revenue upside of about 2% to the fiscal Q1 Street estimate of $664 million. MongoDB is working to establish Enterprise Advanced/Atlas feature parity, adding Search/Vector Search features, which could offer a boost in the second half of fiscal 2027, the brokerage added.
MongoDB's very strong cRPO coverage ratio reinforces confidence in normal fiscal Q1 upside, with potential for incrementally higher Atlas contribution over multiple quarters, according to the note.
Oppenheimer kept an outperform rating on MongoDB with a price target of $375.
Shares of MongoDB rose more than 5% in Tuesday trading.
Price: $312.84, Change: $+18.19, Percent Change: +6.17%